Cidara Thera
(CDTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 88,628 | 27,384 | 25,269 | 54,182 | 17,394 |
| Operating Income | -88,628 | -27,384 | -25,269 | -54,182 | -17,394 |
| Other Income | 5,395 | 1,666 | 1,789 | 1,813 | 1,859 |
| Pre-tax Income | -83,233 | -25,718 | -23,480 | -52,369 | -15,535 |
| Net Income Continuous | -83,233 | -25,718 | -23,480 | -52,369 | -15,535 |
| Net Income Discontinuous | N/A | N/A | N/A | 62 | -450 |
| Net Income | $-83,233 | $-25,718 | $-23,480 | $-52,307 | $-15,985 |
| EPS Basic Total Ops | -3.10 | -1.65 | -1.66 | -2.03 | -2.45 |
| EPS Basic Continuous Ops | -3.10 | -1.65 | -1.66 | -1.99 | -2.38 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.05 | -0.07 |
| EPS Diluted Total Ops | -3.10 | -1.65 | -1.66 | -2.03 | -2.45 |
| EPS Diluted Continuous Ops | -3.10 | -1.65 | -1.66 | -1.99 | -2.38 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.05 | -0.07 |
| EPS Diluted Before Non-Recurring Items | -1.43 | -1.65 | -1.66 | -5.38 | -2.38 |
| EBITDA(a) | $-88,766 | $-27,357 | $-25,220 | $-54,123 | $-17,333 |